Safety and Efficacy of Gliflozin Group Among Patients with Type 2 Diabetes Including Patient’s Satisfaction in Saudi Arabia

Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2019, Vol 18, Issue 4

Abstract

Introduction: Sodium-Glucose Co-transporter 2 (SGLT2) inhibitors is the newest class of oral hypoglycemic agents that was approved for the management of patients with T2DM. Gliflozin group (Empagliflozin, Dapagliflozin & Canagliflozin) have a unique mechanism of action in reducing hyperglycemia by decreasing renal glucose reabsorption and promoting urinary glucose excretion. The aim of this research is to monitor and evaluate the clinical efficacy and safety of (SGLT2) inhibitors for the treatment of type 2 diabetes. Methodology: This study is a prospective cohort study supported by a questionnaire conducted by patients’ interview. Patients’ lab results were taken at baseline and 3-6 months later. This study, also, compared between two groups of patients; (26 patients) on Dapagliflozin and (23 patients) on Empagliflozin to compare the difference between their effects on HbA1c, FBG, Weight, BMI, LDL, HDL, TG, and total cholesterol. Result: Treatment with gliflozin group resulted in a significant reduction on HbA1c by (1%), FBG by (2.77 mmol/l) and BMI by (0.56 kg/m2 ) over 3 to 6 months. On the other hand, there was no significant difference in the comparison between Dapagliflozin and Empagliflozin group. During Ramadan month (46.2%) of the patients were very satisfied by the effect of gliflozin group, furthermore, no serious side effects were reported this month. Conclusion: Gliflozin group was generally well tolerated, no serious side effect or hypoglycemic events have been reported during or after Ramadan. Empagliflozin have a favorable effect in reducing HbA1c and FBG over Dapagliflozin. However, Dapagliflozin has a better influence on weight reduction.Subject of this study are susceptible to hypoglycemia especially in Ramadan month or fasting days. Also, the rate of night urination in this population is higher which may make them more liable to volume depletion. Additionally, type 2 diabetes patients need to manage their weight to maintain a good glucose control. Compliance and tolerance are always a challenge in patients with chronic disease. Gliflozin group have the following characteristics: a. Less hypoglycemic side effect; b. A positive effect on weight reduction; c. Help in controlling the glucose level; d. Tolerable with no serious side effects. Empagliflozin have a favor effect in reducing HbA1c and FBG over Dapagliflozin. However, Dapagliflozin have a better influence on weight reduction in comparison to Empagliflozin. During Ramadan month (46.2%) of the patients were very satisfied from the effect of gliflozin group. Due to the unique properties of gliflozin group in weight reduction and low risk of hypoglycemia, all these findings make gliflozin group a better choice for obese patients and who are at risk of hypoglycemia. Therefore, in comparison to other hypoglycemic agents as sulfonylureas and insulin therapy, which induce hypoglycemia and weight gain, consider the best option in diabetes treatment.

Authors and Affiliations

Al Hejji R, Al Ghamdi M, Al Haqbani D, Al Anazi B, Al Bajjal S, Al Ghadeer A, Al Najjar A, Al Suwaidan S

Keywords

Related Articles

Late decrease of pCREB in the Basolateral Amygdala by Social Interaction Reward

Background: The transcription factor CREB (cAMP response element-binding protein) has been shown to be activated by drugs of abuse in reward-related brain regions. However, the effects of natural reward on CREB activatio...

Fundus Condition of a Patient with Treacher Collins Syndrome - Case Report

The case report presents a child with Treacher Collins syndrome whose ocular surface was abnormal and accompanied binocular amblyopia, but ophthalmic examinations revealed there were no abnormalities in the fundus surpri...

Relugolix: New 0ral Gonadotropin-Releasing Hormone (GnRH) Antagonist

With the recent development of Gonadotropin-Releasing Hormone (GnRH) analogs, physicians have manipulated gonadotropin secretion and, consequently, to treat sex steroid-dependent hormonal disorders such as central precoc...

The Edge of a Knife

Nature is an extremely competitive place. In order to survive living creatures, need to respond fast enough to harmful changes or attacks. For this purpose, natural evolution has armed organisms with various efficient me...

High Resolution Mass Spectroscopy for Single Cell Analysis

Mass spectroscopy is an important analytical tool that has found pervasive use in numerous fields. This review tries to look at the recent advances in high resolution mass spectroscopy for single cell analysis covering t...

Download PDF file
  • EP ID EP621855
  • DOI 10.26717/BJSTR.2019.18.003173
  • Views 145
  • Downloads 0

How To Cite

Al Hejji R, Al Ghamdi M, Al Haqbani D, Al Anazi B, Al Bajjal S, Al Ghadeer A, Al Najjar A, Al Suwaidan S (2019). Safety and Efficacy of Gliflozin Group Among Patients with Type 2 Diabetes Including Patient’s Satisfaction in Saudi Arabia. Biomedical Journal of Scientific & Technical Research (BJSTR), 18(4), 13708-13714. https://europub.co.uk/articles/-A-621855